Soluble epoxide hydrolase: a promising therapeutic target for cardiovascular diseases.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pharmazie

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 21553642
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.

  2010cited by this paper
• Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.

  2010cited by this paper
• Soluble Epoxide Hydrolase in Atherosclerosis

  2010cited by this paper
• Soluble Epoxide Hydrolase Deficiency Attenuates Neointima Formation in the Femoral Cuff Model of Hyperlipidemic Mice

  2010cited by this paper
• Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.

  2010cited by this paper
• Soluble epoxide hydrolase inhibitors: a patent review

  2010cited by this paper
• Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions.

  2010cited by this paper
• Soluble epoxide hydrolase inhibition modulates vascular remodeling.

  2010cited by this paper
• Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes

  2010cited by this paper
• Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.

  2010cited by this paper
• Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats

  2010cited by this paper
• Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension

  2009cited by this paper
• Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.

  2009cited by this paper
• Role of Soluble Epoxide Hydrolase in the Sex-Specific Vascular Response to Cerebral Ischemia

  2009cited by this paper
• Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.

  2009cited by this paper
• Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function.

  2009cited by this paper
• Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

  2009cited by this paper
• Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.

  2009cited by this paper
• Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

  2009cited by this paper
• Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation and dyslipidemia in apolipoprotein E deficient mice infused with angiotensin II

  2009cited by this paper
• Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.

  2009cited by this paper
• Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy

  2009cited by this paper
• Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation

  2009cited by this paper
• Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease

  2008cited by this paper
• Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia

  2008cited by this paper
• Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways

  2008cited by this paper
• Hydrogen Peroxide Inhibits Cytochrome P450 Epoxygenases: Interaction Between Two Endothelium-Derived Hyperpolarizing Factors

  2008cited by this paper
• Genetic Variation in Soluble Epoxide Hydrolase (EPHX2) Is Associated With an Increased Risk of Ischemic Stroke in White Europeans

  2008cited by this paper
• Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study

  2008cited by this paper
• Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension.

  2008cited by this paper
• Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response

  2008cited by this paper
• Altered Soluble Epoxide Hydrolase Gene Expression and Function and Vascular Disease Risk in the Stroke-Prone Spontaneously Hypertensive Rat

  2008cited by this paper
• Vascular cytochrome p450 enzymes: physiology and pathophysiology.

  2008cited by this paper
• Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.

  2008cited by this paper
• Altered Release of Cytochrome P450 Metabolites of Arachidonic Acid in Renovascular Disease

  2008cited by this paper
• Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.

  2008cited by this paper
• CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study

  2007cited by this paper
• Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble expoxide hydrolase

  2007cited by this paper
• Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking.

  2007cited by this paper
• Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo

  2007cited by this paper
• Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted Mice*

  2007cited by this paper
• Polymorphisms in the Human Soluble Epoxide Hydrolase Gene EPHX2 Linked to Neuronal Survival after Ischemic Injury

  2007cited by this paper
• Soluble Epoxide Hydrolase: A Novel Therapeutic Target in Stroke

  2007cited by this paper
• Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.

  2006cited by this paper
• Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function

  2006cited by this paper
• Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.

  2006cited by this paper
• Cytochrome P450 Epoxygenase Gene Function in Hypoxic Pulmonary Vasoconstriction and Pulmonary Vascular Remodeling

  2006cited by this paper
• Endothelium-derived epoxyeicosatrienoic acids and vascular function.

  2006cited by this paper
• The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis

  2006cited by this paper
• Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

  2006cited by this paper
• Soluble epoxide hydrolase is a therapeutic target for acute inflammation.

  2005cited by this paper
• An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension

  2005cited by this paper
• The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.

  2005cited by this paper
• Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients.

  2005cited by this paper
• Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.

  2005cited by this paper
• Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2

  2004cited by this paper
• Polymorphism of the Soluble Epoxide Hydrolase Is Associated With Coronary Artery Calcification in African-American Subjects: The Coronary Artery Risk Development In Young Adults (CARDIA) Study

  2004cited by this paper
• Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis.

  2004cited by this paper
• Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure.

  2004cited by this paper
• Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.

  2004cited by this paper
• Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred

  2004cited by this paper
• The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity

  2003cited by this paper
• Polymorphisms in human soluble epoxide hydrolase.

  2003cited by this paper
• The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase

  2003cited by this paper
• Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension

  2002cited by this paper
• Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids

  2000cited by this paper
• Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation*

  2000cited by this paper
• Identification and Functional Characterization of Human Soluble Epoxide Hydrolase Genetic Polymorphisms*

  2000cited by this paper
• Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

  1999cited by this paper
• Asp333, Asp495, and His523 form the catalytic triad of rat soluble epoxide hydrolase.

  1996cited by this paper
• Asp, Asp, and His Form the Catalytic Triad of Rat Soluble Epoxide Hydrolase (*)

  1996cited by this paper

• The differences in brain stem transcriptional profiling in hypertensive ISIAH and normotensive WAG rats

  2019cites this paper
• Stress, Genes, and Hypertension. Contribution of the ISIAH Rat Strain Study

  2018cites this paper
• Soluble epoxide hydrolase (sEH) as a potential target for arterial hypertension therapy

  2017cites this paper
• Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection.

  2016cites this paper
• Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): A Promising Therapeutic Target for Cardiovascular Diseases

  2016cites this paper
• Vascular Endothelial Function in Ischemia/Reperfusion Injury: Pathophysiological Mechanisms and Clinical Implications for Postischemic Myocardial Protection

  2015cites this paper
• Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.

  2015cites this paper
• In vitro inhibitory effects of ethanol extract of Danshen (Salvia miltiorrhiza) and its components on the catalytic activity of soluble epoxide hydrolase.

  2015cites this paper
• Endothelial control of vasodilation: integration of myoendothelial microdomain signalling and modulation by epoxyeicosatrienoic acids

  2014cites this paper
• Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.

  2014cites this paper
• Mechanism of the Sex Difference in Endothelial Dysfunction after Stroke

  2013cites this paper
• EETs mediate cardioprotection of salvianolic acids through MAPK signaling pathway

  2013cites this paper
• Effects of soluble epoxide hydrolase inhibitor on the expression of fatty acid synthase in peripheral blood mononuclear cell in patients with acute coronary syndrome

  2013cites this paper
• Diversity in Mechanisms of Endothelium‐Dependent Vasodilation in Health and Disease

  2013cites this paper
• t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65

  2012cites this paper
• Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability.

  2012cites this paper
• Protection of salvianolic acid A on rat brain from ischemic damage via soluble epoxide hydrolase inhibition

  2012cites this paper
• High-Throughput Screening for Novel Prostate Cancer Drug Targets –Getting Personal

  2011cites this paper